Active-ingredient Dossier
"pertussis Filamentous Haemagglutinin"
Active-ingredient Dossier for "pertussis Filamentous Haemagglutinin" (pertussis vaccine component). Australian brands, products, PBS listings, PBAC…
- Brand: HEXAXIM
- Therapeutic area: Infectious Disease
What is
Pertussis Filamentous Haemagglutinin Pertussis Filamentous Haemagglutinin is a pertussis vaccine component.
Australian brands containing
Pertussis Filamentous Haemagglutinin — ADACEL — BOOSTRIX — BOOSTRIX-IPV — HEXAXIM — INFANRIX — INFANRIX-IPV — QUADRACEL — TRIPACEL — VAXELIS
Therapeutic areas
Pertussis Filamentous Haemagglutinin is registered in Infectious Disease (7 brands) and Immunology (2 brands).
Sponsor landscape
The ingredient is marketed by three sponsors: Sanofi-Aventis, GlaxoSmithKline, and Maxx Pharma.
PBS and regulatory activity
Two brands containing Pertussis Filamentous Haemagglutinin have PBAC outcomes on record, with the latest PBAC outcome recorded on 1 March 2017. No AusPARs are on record for this ingredient.